Come up with a name for your new list and we'll add to it:
Zymeworks raised a round of funding on October 23, 2014. Investors include
Eli Lilly & Co..
Zymeworks (NYSE: ZYME) (TSX: ZYME) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of multifunctional biotherapeutics.…